Your session is about to expire
← Back to Search
Renuva for Fat Pad Syndrome
Study Summary
This trial looks at how a medical treatment can help people with fat pad impingement to regrow fat pads.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently receiving treatment for cancer, excluding non-melanoma skin cancers.I have had or currently have an infection in my affected joint.I am between 18 and 85 years old.I have a condition like rheumatoid arthritis or lupus affecting my joints.I have a health condition that could affect my treatment results.I have been diagnosed with gout or pseudogout.I can attend all required follow-up appointments.I have been diagnosed with fat pad impingement.
- Group 1: Renuva Injection
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this trial encompass geriatric individuals?
"This research is accepting participants who are aged 18 years and over, but not yet 85."
Would I be allowed to participate in this research project?
"This research endeavour is recruiting up to five participants with fat pad syndrome age 18 and 85."
What protective measures have been implemented to ensure the safety of those who receive Renuva Injection?
"Since Renuva Injection is still in its first phase of clinical trials, there's limited evidence to support its safety and efficacy. As a result, it was given an assessment score of 1 on our rating scale at Power."
Is this research project presently seeking participants?
"Clinicaltrials.gov corroborates that this medical experiment, posted in April of 2023 and altered late May, is actively looking for participants."
What is the current patient cohort participating in this experiment?
"True, clinicaltrials.gov states that this medical study is actively pursuing participants. Initially published on April 22nd of 2023 and last modified on May 26th of 2023, the trial requires 5 individuals from 2 separate research facilities to take part in it."
What is the overarching purpose of this clinical experiment?
"The primary objective of this 6-month study is to examine the surface area (in millimeters squared) of fat pads in Knee MRIs. Secondary endpoints include KOOS Symptoms, which evaluates both short and long-term knee symptoms on a 0-100 scale where 100 implies no pain or discomfort; KOOS ADL, which assesses function when performing daily living activities with the same scoring system as before; and finally, KOOS Sport/Rec, an evaluation for sports or recreational activity that again uses a 0-100 rating system."
Share this study with friends
Copy Link
Messenger